- IN₹1.29bn
- IN₹2.78bn
- IN₹3.12bn
Brief: Bal Pharma Commences Setting Up Of Green Field Project For 300 Million Rupees
Brief: Bal Pharma Dividend Of 1 Rupee Per Share
Brief: Bal Pharma Names Bharath Bhushan D.V As CFO
Brief: Bal Pharma CFO G.Renagarajan Resigns
Recommended Dividend Of 1 Rupee Per Share
Brief: Bal Pharma Launches Favipiravir Formulation Under Brand Name BALflu
Proposed To Evaluate Option For Sale Of IV Fluid Making Vertical
Refinitiv Newscasts - US Morning Call: Futures slip after Wall Street ends at record highs
Brief: Bal Pharma Says To Consider Monetization Of IV Fluid Manufacturing Facility
Brief: India's Bal Pharma Posts June Qtr Net Profit
Approved Raising Of Capital Through Preferential Issue Of Warrants
Brief: India's Bal Pharma Posts Dec-Quarter Consol Net Loss
India's Bal Pharma climbs on receipt of EU GMP certification
Brief: Bal Pharma Gets EU GMP Approval For Its Formulations Manufacturing Plant
Brief: India's Bal Pharma Dec Qtr Net Profit Falls
Brief: Bal Pharma's Udaipur Bulk Drugs Manufacturing Unit Starts Commercial Production Of Intermediates, Active Pharma Ingredients
Brief: Bal Pharma Gets Shareholders' Nod For Increase In The Investment Limits Of NRIs And FPIs
Brief: India's Bal Pharma June-Qtr Profit Surges
Brief: Bal Pharma Acquires Golden Drugs Private Limited